Danish pharma giant Novo Nordisk disclosed a cybersecurity incident last week, and although the firm’s name may not be familiar to everyone, they are a major producer of insulin and semaglutide. Semaglutide is marketed as Wegovy for weight loss and Ozempic for Type 2 diabetes. In its June 11 update, the firm stated that the... Source